Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP334387.RADaMrjPF-L_vI80IEexoWjv13zUqSdd4nkYdVGPmWAnI130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334387.RADaMrjPF-L_vI80IEexoWjv13zUqSdd4nkYdVGPmWAnI130_provenance.
• NP425545.RAd0YLiad-2ttI8UUsq9BTytKb5gT1ezvbrfTKPVKgNpk130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425545.RAd0YLiad-2ttI8UUsq9BTytKb5gT1ezvbrfTKPVKgNpk130_provenance.
• NP333780.RAtXHBhE9P-BdxFdHfSy_BItQH-Olk1wkYcso_QogVW4U130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333780.RAtXHBhE9P-BdxFdHfSy_BItQH-Olk1wkYcso_QogVW4U130_provenance.
• NP433354.RAuSzQ7xnrXU79nKxTWtxkw1QVa_33yHkWXV9BHWiPzn8130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433354.RAuSzQ7xnrXU79nKxTWtxkw1QVa_33yHkWXV9BHWiPzn8130_provenance.
• NP582325.RArXzOm2REAnWnZhhbkiOkRIkkasoP_udUzBznGTy_lj4130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582325.RArXzOm2REAnWnZhhbkiOkRIkkasoP_udUzBznGTy_lj4130_provenance.
• NP375427.RAU0HilB_GjUdJHRoe1oJd4Rck_ry7q1gLwyec42b93V8130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375427.RAU0HilB_GjUdJHRoe1oJd4Rck_ry7q1gLwyec42b93V8130_provenance.
• NP648917.RAgkls8Z47f_B4OpSyRnaSlUKeomNryWeBipRoVVrE-Es130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP648917.RAgkls8Z47f_B4OpSyRnaSlUKeomNryWeBipRoVVrE-Es130_provenance.
• NP252690.RAHSo1ITTRgIzwSFwNz9Y7NHfcdlGFQMmfl5vzXYrXPOI130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252690.RAHSo1ITTRgIzwSFwNz9Y7NHfcdlGFQMmfl5vzXYrXPOI130_provenance.
• assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP919783.RAYCynxSZgaqaXyfMSD7AmnP3jqycHFYByDdPuSTgel4Q130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919783.RAYCynxSZgaqaXyfMSD7AmnP3jqycHFYByDdPuSTgel4Q130_provenance.
• NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600542.RAHl-NTOtaPFxc2-bax653C9hQ3usDF-r1z_N9jjoIaX0130_provenance.
• NP962988.RAUXqb_abbVgVXsfNdAmlQW471M1B3qEF3wCGRMqxKDzs130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962988.RAUXqb_abbVgVXsfNdAmlQW471M1B3qEF3wCGRMqxKDzs130_provenance.
• NP288479.RAutmCVfIucRXe-sHZOpPUY_rW8MmXlQrv7ocfzg3f22k130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288479.RAutmCVfIucRXe-sHZOpPUY_rW8MmXlQrv7ocfzg3f22k130_provenance.
• assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP538801.RAg_AfY3yF4YfscpwoK5iQeJq1z3fh15v04YXKMr_uNt8130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538801.RAg_AfY3yF4YfscpwoK5iQeJq1z3fh15v04YXKMr_uNt8130_provenance.
• NP538799.RA_9urLOp6hHK1fq1hGWVu-HGS2KcyABD0r7LSNmy-NGM130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538799.RA_9urLOp6hHK1fq1hGWVu-HGS2KcyABD0r7LSNmy-NGM130_provenance.
• NP538800.RA2syLJC6h0Cq_ByjG0xeCf-KjGOBACiGSSUGzlcgnUiM130_assertion description "[Patients infected with HBV harboring TCC had more liver cirrhosis than those infected with HBV harboring CCC (18% versus 5%; P = 0.008), and more of the patients infected with HBV harboring TCC were positive for HBeAg (58% versus 36%; P = 0.01) and had higher median alanine aminotransferase levels (65 IU/liter versus 49 IU/liter; P = 0.006); but similar proportions of patients infected with HBV harboring TCC and those infected with HBV harboring CCT had liver cirrhosis (18% versus 13%; P = 0.43).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538800.RA2syLJC6h0Cq_ByjG0xeCf-KjGOBACiGSSUGzlcgnUiM130_provenance.